Bilde av Hovd, Rebekka Rolfsnes
Bilde av Hovd, Rebekka Rolfsnes
Postdoctoral Fellow Department of Medical Biology rebekka.r.hovd@uit.no Tromsø

Rebekka Rolfsnes Hovd


Job description

Postdoctoral researcher in the LacZymes research group, part of the broader Host-Microbe Interactions (HMI) research group at the Department of Medical Biology.

I completed my PhD in January 2026, researching adjuvants capable of inhibiting β-lactamases, which cause β-lactam resistance in bacteria. My ongoing research focuses on using in vitro models to understand bacterial evolution and adaptation, with an emphasis on clinically relevant isolates. My goal is to contribute to our understanding of how bacterial tolerance and resistance to antibiotics influence clinical treatment outcomes.


  • Rebekka Rolfsnes Hovd, Åsmund Kaupang, Pål Rongved, Geir Kildahl-Andersen, Knut Tormodssønn Hylland, Ragnar Hovland et al.:
    APC24-7, a covalent combination of boronic acid and chelator moieties, restores β-lactam efficiency against metallo-β-lactamase-producers
    mSphere 03. December 2025 DOI / ARKIV
  • Helene Liepelt Nystedt, Krister Gjestvang Grønlien, Rebekka Rekkedal Rolfsnes, Hanne Cecilie Winther-Larsen, Ole Andreas Økstad, Hanne Hjorth Tønnesen :
    Neutral natural deep eutectic solvents as anti-biofilm agents
    Biofilm 2023 DOI / ARKIV / ARKIV
  • Rebekka Rolfsnes Hovd :
    Antibiotic adjuvants to reverse β-lactam resistance: Mechanism of action and resistance development of chelator-based metallo-β-lactamase inhibitors
    Universitetet i Oslo 2026 ARKIV
  • Rebekka Rolfsnes Hovd, Pål Rongved, Ragnar Hovland, Åsmund Kaupang, Christopher Frøhlich, Sandra Huber et al.:
    Investigating the Mechanism of Action of a Novel Dual β-Lactamase Inhibitor
    2023 ARKIV
  • Rebekka Rolfsnes Hovd, Pål Rongved, Ragnar Hovland, Åsmund Kaupang, Christopher Frøhlich, Sandra Huber et al.:
    Investigating the Mechanism of Action of a New Novel Dual β-Lactamase Inhibitor
    2023 ARKIV
  • Rebekka Rolfsnes Hovd, Pål Rongved, Bjørn Klem, Ragnar Hovland, Åsmund Kaupang, Ole Andreas Løchen Økstad et al.:
    Bacterial antimicrobial resistance mechanisms - The novel dual serine- and metallo-β-lactamase inhibitor APC247
    2022 ARKIV
  • Rebekka Rolfsnes Hovd, Pål Rongved, Bjørn Klem, Ragnar Hovland, Geir Kildahl-Andersen, Åsmund Kaupang et al.:
    The novel antimicrobial resistance breaker APC247 – a putative dual serine- and metallo-β-lactamase inhibitor
    2022 ARKIV

  • The 50 latest publications is shown on this page. See all publications in NVA here →